<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04172870</url>
  </required_header>
  <id_info>
    <org_study_id>MADC/IRB/2017/260</org_study_id>
    <secondary_id>FLL/IRC/01/2017</secondary_id>
    <nct_id>NCT04172870</nct_id>
  </id_info>
  <brief_title>Evaluation of Inflammatory Markers and Periodontal Viruses on Periodontitis Patients With CAD</brief_title>
  <official_title>Evaluation of Demographic Variables, Clinical Parameters, Inflammatory Markers and Viruses in Periodontitis Patients With Coronary Artery Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meenakshi Ammal Dental College and Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meenakshi Ammal Dental College and Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess and compare the demographic variables, periodontal parameters, cardiac parameters
      and the expression of periodontal viruses (CMV, HSV and EBV) and inflammatory
      biomarkers(PTX-3, TLR-2 &amp; TLR-4) in periodontally healthy and generalized periodontitis
      patients with and without coronary artery disease(CAD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 240 subjects will be recruited based on the power of the study. The selected
      subjects will be divided into four groups based on the inclusion and exclusion criteria.

        1. GROUP I: 60 healthy subjects ( No generalised periodontitis and no CAD)

        2. GROUP II: 60 generalised periodontitis subjects without CAD

        3. GROUP III: 60 CAD subjects without generalised periodontitis

        4. GROUP IV: 60 subjects with Generalised periodontitis and CAD

      Sub-gingival plaque samples will be collected from the subjects of all the four groups.
      Coronary artery plaque samples will be collected from the patients who were indicated for
      coronary artery bypass graft surgery (CABG) among group III and group IV.

      The demographic variables , periodontal parameters , cardiac parameters , expression of
      periodontal viruses and inflammatory biomarkers will be measured in all four groups ,
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 15, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Periodontal Virus and Inflammatory Markers expression in periodontitis patients with coronary artery disease</measure>
    <time_frame>2 years</time_frame>
    <description>Expression of EBV, CMV, HSV, Pentraxins, TLR 2 and TLR 4 using PCR</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">240</enrollment>
  <condition>Periodontitis</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Group I</arm_group_label>
    <description>Healthy group ( No generalised periodontitis and no CAD)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II</arm_group_label>
    <description>Generalised periodontitis patients without CAD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group III</arm_group_label>
    <description>CAD patients without generalised periodontitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group IV</arm_group_label>
    <description>Generalised periodontitis with CAD</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Molecular analysis</intervention_name>
    <description>RT- PCR</description>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_label>Group III</arm_group_label>
    <arm_group_label>Group IV</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Subgingival plaque sample, Atherosclerotic plaque samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Indian Population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients willing to participate in the study.

          2. Patients with 30 to 65 years of age group

          3. Both genders

          4. Patients should have minimum of 10 natural teeth.

          5. In case of group III and IV patients with coronary heart disease to be included.

        Exclusion Criteria

          1. Patients who had undergone periodontal therapy within the previous 6 months.

          2. Type I and II Diabetes mellitus

          3. Sarcoidosis patients.

          4. Carcinoma patients.

          5. Rheumatic arthritis patients.

          6. Tuberculosis patients.

          7. Immunosuppressive conditions.

          8. Patients with other inflammatory diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaideep Mahendra, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MeenakshiAmmal Dental College &amp; Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MeenakshiAmmal Dental College and Hospital</name>
      <address>
        <city>Chennai</city>
        <state>TamilNadu</state>
        <zip>600095</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <reference>
    <citation>Gurses KM, Kocyigit D, Yalcin MU, Canpinar H, Oto MA, Ozer N, Tokgozoglu L, Guc D, Aytemir K. Enhanced Platelet Toll-like Receptor 2 and 4 Expression in Acute Coronary Syndrome and Stable Angina Pectoris. Am J Cardiol. 2015 Dec 1;116(11):1666-71. doi: 10.1016/j.amjcard.2015.08.048. Epub 2015 Sep 11.</citation>
    <PMID>26455385</PMID>
  </reference>
  <reference>
    <citation>Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM. Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):594-9. doi: 10.1161/ATVBAHA.108.178947. Epub 2009 Jan 22.</citation>
    <PMID>19164811</PMID>
  </reference>
  <reference>
    <citation>Imbronito AV, Marcelino SL, Grande SR, Nunes FD, Romito GA. Detection of human cytomegalovirus and epstein-barr virus in coronary atherosclerotic tissue. Braz J Microbiol. 2010 Jul;41(3):563-6. doi: 10.1590/S1517-83822010000300004. Epub 2010 Sep 1.</citation>
    <PMID>24031529</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 20, 2019</study_first_submitted>
  <study_first_submitted_qc>November 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meenakshi Ammal Dental College and Hospital</investigator_affiliation>
    <investigator_full_name>Dr.Jaideep Mahendra</investigator_full_name>
    <investigator_title>Professor and Director of PG studies</investigator_title>
  </responsible_party>
  <keyword>Ebstein Barr Virus</keyword>
  <keyword>Cytomegalovirus</keyword>
  <keyword>Herpes Simplex Virus</keyword>
  <keyword>Pentraxins</keyword>
  <keyword>Toll Like Receptors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Perio-Continuum link could be shared through publications</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

